⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for adult anaplastic oligodendroglioma

Every month we try and update this database with for adult anaplastic oligodendroglioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant GliomaNCT00516282
Brain and Centr...
CLORETAZINE
temozolomide
18 Years - Northwestern University
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain TumorsNCT00499798
Brain and Centr...
Chemotherapeuti...
Infertility
18 Years - 60 YearsWake Forest University Health Sciences
Suramin in Treating Patients With Recurrent Primary Brain TumorsNCT00002639
Brain and Centr...
chemotherapy
suramin
15 Years - National Cancer Institute (NCI)
Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic OligodendrogliomaNCT00002840
Brain and Centr...
lomustine
procarbazine hy...
vincristine sul...
radiation thera...
16 Years - 69 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant GliomaNCT00005951
Brain and Centr...
irinotecan hydr...
temozolomide
18 Years - Duke University
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaNCT01103375
Adult Anaplasti...
Adult Anaplasti...
Adult Diffuse A...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Oligodend...
Recurrent Adult...
erlotinib hydro...
isotretinoin
laboratory biom...
protein express...
18 Years - Wake Forest University Health Sciences
Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid TumorsNCT00008086
Brain and Centr...
Unspecified Adu...
calcitriol
carboplatin
18 Years - University of Pittsburgh
Temozolomide in Treating Patients With Recurrent High-Grade GliomaNCT00619112
Recurrent Centr...
temozolomide
18 Years - University of California, San Francisco
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain TumorsNCT00002647
Brain and Centr...
Metastatic Canc...
verteporfin
conventional su...
3 Years - 70 YearsNational Cancer Institute (NCI)
VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to TemozolomideNCT00369590
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Gliosarco...
Recurrent Adult...
ziv-aflibercept
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Temozolomide in Treating Patients With Recurrent or Progressive Malignant GliomaNCT00004204
Brain and Centr...
temozolomide
18 Years - National Cancer Institute (NCI)
Bevacizumab in Recurrent Grade II and III GliomaNCT01164189
Central Nervous...
Bevacizumab
Temozolomide
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With OligodendrogliomaNCT00003101
Brain and Centr...
filgrastim
busulfan
lomustine
procarbazine hy...
thiotepa
vincristine sul...
autologous bone...
peripheral bloo...
18 Years - Memorial Sloan Kettering Cancer Center
Vaccine Therapy in Treating Patients With Malignant GliomaNCT00612001
Brain and Centr...
glioma-associat...
18 Years - Jonsson Comprehensive Cancer Center
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain CancerNCT00025558
Brain and Centr...
filgrastim
carboplatin
temozolomide
thiotepa
autologous bone...
peripheral bloo...
1 Year - 49 YearsNYU Langone Health
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain TumorsNCT00005083
Brain and Centr...
conventional su...
magnetic resona...
magnetic resona...
18 Years - 55 YearsJonsson Comprehensive Cancer Center
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant GliomaNCT00401024
Brain and Centr...
imatinib mesyla...
pharmacological...
conventional su...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain TumorNCT00069940
Brain and Centr...
Gastrointestina...
Sarcoma
sargramostim
telomerase: 540...
2 Years - Dana-Farber Cancer Institute
Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant GliomaNCT00087061
Brain and Centr...
gimatecan
18 Years - National Cancer Institute (NCI)
Procarbazine in Treating Patients With Recurrent Brain TumorNCT00004004
Brain and Centr...
procarbazine hy...
18 Years - National Cancer Institute (NCI)
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant GliomaNCT00352313
Brain and Centr...
ATN-161
carboplatin
18 Years - National Institutes of Health Clinical Center (CC)
MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic GliomaNCT00756106
Brain and Centr...
temozolomide
Imaging biomark...
Photon Radiatio...
18 Years - Massachusetts General Hospital
Fenretinide in Treating Patients With Recurrent Malignant GliomaNCT00006080
Brain and Centr...
fenretinide
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Melphalan With BBBD in Treating Patients With Brain MalignanciesNCT00253721
Brain and Centr...
Lymphoma
Metastatic Canc...
Melphalan
18 Years - 120 YearsOHSU Knight Cancer Institute
Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaNCT00010049
Brain and Centr...
imatinib mesyla...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain TumorNCT00070161
Brain and Centr...
Radiation Toxic...
EGb761
donepezil hydro...
cognitive asses...
18 Years - 120 YearsWake Forest University Health Sciences
Karenitecin in Treating Patients With Recurrent Malignant GliomaNCT00014521
Brain and Centr...
karenitecin
18 Years - National Cancer Institute (NCI)
EMD 121974 in Treating Patients With Progressive or Recurrent GliomaNCT00006093
Brain and Centr...
cilengitide
18 Years - National Cancer Institute (NCI)
Chemotherapy in Treating Patients With Progressive or Recurrent Brain TumorsNCT00012038
Brain and Centr...
irofulven
18 Years - National Cancer Institute (NCI)
Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed GliomaNCT00005082
Brain and Centr...
biopsy
magnetic resona...
18 Years - Jonsson Comprehensive Cancer Center
Carmustine in Treating Patients With Recurrent Malignant GliomaNCT00004028
Brain and Centr...
carmustine
conventional su...
18 Years - National Cancer Institute (NCI)
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant GliomaNCT00897611
High Grade Glio...
DNA methylation...
polymerase chai...
computed tomogr...
magnetic resona...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Monoclonal Antibody Therapy in Treating Patients With Recurrent GliomasNCT00002753
Brain and Centr...
iodine I 131 mo...
3 Years - Duke University
Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant GliomaNCT00301873
Brain Tumors
Osteoporosis
Central Nervous...
IV Zometa
18 Years - Duke University
High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent GliomaNCT01378481
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Recurrent Adult...
Vorinostat
Stereotactic Ra...
Laboratory Biom...
Pharmacological...
Therapeutic Con...
18 Years - National Cancer Institute (NCI)
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent GliomasNCT02175745
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Diffuse A...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Oligodend...
Adult Pilocytic...
Adult Pineal Gl...
Adult Subependy...
Childhood High-...
Childhood High-...
Childhood Low-g...
Childhood Low-g...
Recurrent Adult...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Recurrent Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
Untreated Child...
18F-fluoro-dihy...
Positron emissi...
Computed tomogr...
Magnetic resona...
16 Years - Stanford University
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord TumorsNCT00541138
Brain and Centr...
Metastatic Canc...
Unspecified Adu...
carboplatin
tamoxifen citra...
topotecan hydro...
pharmacological...
18 Years - City of Hope Medical Center
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsNCT00002608
Adrenocortical ...
Brain and Centr...
Head and Neck C...
Liver Cancer
Malignant Mesot...
Pheochromocytom...
Sarcoma
cisplatin
doxorubicin hyd...
tamoxifen citra...
conventional su...
radiation thera...
- 65 YearsNational Cancer Institute (NCI)
Temozolomide in Treating Patients With Anaplastic OligodendrogliomaNCT00003465
Brain and Centr...
temozolomide
18 Years - Duke University
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain CancerNCT00025558
Brain and Centr...
filgrastim
carboplatin
temozolomide
thiotepa
autologous bone...
peripheral bloo...
1 Year - 49 YearsNYU Langone Health
FR901228 in Treating Patients With Recurrent High-Grade GliomasNCT00085540
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Gliosarco...
Recurrent Adult...
depsipeptide
18 Years - National Cancer Institute (NCI)
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesNCT02967380
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Choroid P...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade II ...
Adult Medullobl...
Adult Mixed Gli...
Adult Oligodend...
Adult Papillary...
Adult Pineal Gl...
Adult Pineoblas...
Adult Primary M...
Adult Supratent...
Malignant Adult...
Metastatic Mali...
Multiple Sclero...
Recurrent Adult...
Dynamic Contras...
Gadobenate Dime...
Gadobutrol
Gadopentetate D...
18 Years - University of Southern California
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial GliomasNCT00083096
Brain and Centr...
lonafarnib
temozolomide
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Dietary, Herbal and Alternative Medicine in Glioblastoma MultiformeNCT00243022
Brain and Centr...
Cerebral Edema
Boswellia serra...
cyanocobalamin
18 Years - Case Comprehensive Cancer Center
Bortezomib in Treating Patients With Recurrent GliomaNCT00006773
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
bortezomib
18 Years - National Cancer Institute (NCI)
Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2NCT01082926
Anaplastic Astr...
Anaplastic Epen...
Anaplastic Meni...
Anaplastic Olig...
Brain Stem Glio...
Ependymoblastom...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Grade III Menin...
Meningeal Heman...
Mixed Glioma
Pineal Gland As...
Brain Tumor
therapeutic all...
aldesleukin
laboratory biom...
positron emissi...
18 Years - 70 YearsCity of Hope Medical Center
Dietary, Herbal and Alternative Medicine in Glioblastoma MultiformeNCT00243022
Brain and Centr...
Cerebral Edema
Boswellia serra...
cyanocobalamin
18 Years - Case Comprehensive Cancer Center
Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic GliomaNCT00058123
Brain and Centr...
poly ICLC
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial AstrocytomaNCT00999622
Brain and Centr...
Infection
laboratory biom...
questionnaire a...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain TumorsNCT00003478
Brain and Centr...
conventional su...
iodine I 131 mo...
radiation thera...
18 Years - Duke University
Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade GliomaNCT01095094
Brain Tumor
Anaplastic Astr...
Anaplastic Epen...
Anaplastic Olig...
Brain Stem Glio...
Giant Cell Glio...
Glioblastoma
Gliosarcoma
Mixed Glioma
ritonavir
lopinavir
18 Years - Case Comprehensive Cancer Center
Bevacizumab in Recurrent Grade II and III GliomaNCT01164189
Central Nervous...
Bevacizumab
Temozolomide
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant GliomaNCT00079092
Brain and Centr...
procarbazine hy...
thalidomide
18 Years - 120 YearsWake Forest University Health Sciences
Fenretinide in Treating Patients With Recurrent Malignant GliomaNCT00006080
Brain and Centr...
fenretinide
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Topotecan in Treating Patients With Recurrent Brain TumorsNCT00003372
Brain and Centr...
topotecan hydro...
18 Years - 120 YearsCanadian Cancer Trials Group
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain TumorsNCT00110032
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Brain Ste...
Adult Central N...
Adult Choroid P...
Adult Craniopha...
Adult Diffuse A...
Adult Ependymob...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Grade I M...
Adult Grade II ...
Adult Grade III...
Adult Medullobl...
Adult Meningeal...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Pineoblas...
Adult Pineocyto...
Adult Subependy...
Adult Supratent...
Meningeal Melan...
EF5
conventional su...
positron emissi...
fluorine F 18 E...
pharmacological...
18 Years - National Cancer Institute (NCI)
Dietary, Herbal and Alternative Medicine in Glioblastoma MultiformeNCT00243022
Brain and Centr...
Cerebral Edema
Boswellia serra...
cyanocobalamin
18 Years - Case Comprehensive Cancer Center
Temozolomide in Treating Patients With Recurrent Malignant GliomaNCT00004113
Brain and Centr...
temozolomide
18 Years - Memorial Sloan Kettering Cancer Center
Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsNCT00002754
Brain and Centr...
Melanoma (Skin)
Metastatic Canc...
monoclonal anti...
3 Years - Duke University
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant GliomaNCT00112736
Adult Anaplasti...
Adult Anaplasti...
Adult Diffuse A...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Pilocytic...
Adult Pineal Gl...
Adult Subependy...
Recurrent Adult...
erlotinib
temsirolimus
therapeutic con...
laboratory biom...
pharmacological...
18 Years - National Cancer Institute (NCI)
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesNCT01234740
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Recurrent Adult...
Tumors Metastat...
Adult Anaplasti...
bafetinib
microdialysis
pharmacological...
liquid chromato...
mass spectromet...
laboratory biom...
protein express...
western blottin...
immunohistochem...
therapeutic con...
18 Years - City of Hope Medical Center
Study of Tissue Samples From Patients With Glioma or Other Brain TumorsNCT00967200
Central Nervous...
laboratory biom...
pharmacogenomic...
18 Years - 120 YearsUniversity Hospital, Montpellier
Chemotherapy in Treating Patients With Progressive or Recurrent Brain TumorsNCT00012038
Brain and Centr...
irofulven
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant GliomaNCT00005637
Brain and Centr...
carmustine
temozolomide
18 Years - National Cancer Institute (NCI)
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain MetastasesNCT01234740
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Recurrent Adult...
Tumors Metastat...
Adult Anaplasti...
bafetinib
microdialysis
pharmacological...
liquid chromato...
mass spectromet...
laboratory biom...
protein express...
western blottin...
immunohistochem...
therapeutic con...
18 Years - City of Hope Medical Center
Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma MultiformeNCT00892177
Glioblastoma Mu...
bevacizumab
dasatinib
placebo
18 Years - Alliance for Clinical Trials in Oncology
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial AstrocytomaNCT00999622
Brain and Centr...
Infection
laboratory biom...
questionnaire a...
18 Years - Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant GliomaNCT00430079
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Diffuse A...
Adult Ependymom...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Adult Myxopapil...
Adult Oligodend...
Adult Pilocytic...
Adult Pineal Gl...
Adult Subependy...
etanidazole
conventional su...
pharmacological...
laboratory biom...
18 Years - National Cancer Institute (NCI)
Temozolomide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Anaplastic Oligodendrogliomas or Mixed Anaplastic OligoastrocytomasNCT00033280
Brain and Centr...
temozolomide
neoadjuvant the...
radiation thera...
18 Years - 65 YearsRadiation Therapy Oncology Group
Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade GliomaNCT00463008
Brain and Centr...
methotrexate
pharmacological...
18 Years - National Cancer Institute (NCI)
Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With GliomaNCT00631137
Brain and Centr...
Musculoskeletal...
testosterone ge...
whey powder pro...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chemotherapy in Treating Patients With Progressive or Recurrent Brain TumorsNCT00012038
Brain and Centr...
irofulven
18 Years - National Cancer Institute (NCI)
Suramin in Treating Patients With Recurrent Primary Brain TumorsNCT00002639
Brain and Centr...
chemotherapy
suramin
15 Years - National Cancer Institute (NCI)
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary GliomaNCT00027625
Brain and Centr...
gefitinib
temozolomide
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
3T MRI Biomarkers of Glioma Treatment ResponseNCT01996527
Adult Anaplasti...
Adult Anaplasti...
Adult Anaplasti...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Recurrent Adult...
3-Tesla magneti...
CEST-MRI
DW-MRI
DCE-MRI
DSC-MRI
IV administrati...
18 Years - Vanderbilt-Ingram Cancer Center
Carmustine Followed By Surgery in Treating Patients With Recurrent Supratentorial Malignant Glioma or Metastatic Brain NeoplasmNCT00009854
Brain and Centr...
Metastatic Canc...
carmustine in e...
conventional su...
18 Years - 75 YearsNational Cancer Institute (NCI)
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)NCT00626990
Brain and Centr...
temozolomide
DNA methylation...
laboratory biom...
adjuvant therap...
quality-of-life...
radiation thera...
18 Years - 120 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade GliomasNCT01172964
Adult Anaplasti...
Recurrent Grade...
Recurrent Grade...
Adult Anaplasti...
Adult Brain Tum...
Adult Giant Cel...
Adult Glioblast...
Adult Gliosarco...
Adult Mixed Gli...
Recurrent Adult...
Adult Anaplasti...
Recurrent High ...
flucytosine
polymerase chai...
immunohistochem...
gene therapy
pharmacological...
3-Tesla magneti...
laboratory biom...
therapeutic con...
E. coli CD-expr...
13 Years - City of Hope Medical Center
Gene Therapy in Treating Patients With Recurrent Malignant GliomasNCT00004041
Brain and Centr...
Ad5CMV-p53 gene
conventional su...
18 Years - 120 YearsSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
CC-5013 in Treating Patients With Recurrent GliomaNCT00036894
Brain and Centr...
lenalidomide
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: